Key result
Fatty liver disease was independently associated with an increased risk of subclinical atherosclerosis in women (HR 1.65), but not in men.
Why the study?
Does fatty liver disease increase subclinical atherosclerosis (measured by CIMT and carotid plaque) differently in men and women?
Cross-Sectional (n=1,121)
No
Does fatty liver disease increase subclinical atherosclerosis (measured by CIMT and carotid plaque) differently in men and women?
Hazard Ratio: 1.65 (95% CI 1.007–2.697)
p-value: p=0.047
Fatty liver disease is an independent predictor of subclinical atherosclerosis in women, highlighting a gender-specific cardiovascular risk factor.
May support sex-specific CV risk evaluation in fatty liver disease; hypothesis-generating and should not yet change practice.
BACKGROUND: Carotid intima-media thickness (CIMT) is a surrogate of subclinical atherosclerosis. Fatty liver disease is also linked to increased risk of cardiovascular events. The aim of this study was to evaluate the association between fatty liver disease and CIMT according to gender. METHODS: Patients who had undergone carotid and abdominal ultrasound between June 2011 and December 2013 were retrospectively evaluated. The differences between the CIMT values measured in the common carotid artery and the prevalence of carotid plaque in patients with fatty liver disease and those with normal livers were investigated. RESULTS: Out of a total of 1 121 patients, the men had more fatty liver disease than the women. The mean CIMT of the men was significantly higher than that of the women, and the men had more plaque than the women. The women with fatty liver disease had a significantly higher mean CIMT value and more plaque than the women with normal livers. The differences between the men with fatty liver and those with normal livers in mean CIMT values and in the prevalence of plaque were not significant. In the women, multivariate analysis showed that fatty liver disease was independently associated with subclinical atherosclerosis [adjusted hazards ratio (HR) 1.65, 95% confidence interval (CI) 1.007-2.697, p = 0.047]. CONCLUSIONS: The men had more fatty liver disease, carotid plaque and higher CIMT values than the women. Fatty liver disease was a useful predictor of atherosclerosis, especially for the female study patients.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2016) conducted a cross-sectional in Fatty liver disease and subclinical atherosclerosis (n=1,121). Fatty liver disease vs. Normal liver was evaluated on Subclinical atherosclerosis (CIMT ≥ 75th percentile or presence of carotid plaque) (HR 1.65, 95% CI 1.007-2.697, p=0.047). Fatty liver disease was independently associated with an increased risk of subclinical atherosclerosis in women (HR 1.65), but not in men.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: